CARLSMED, INC.
About CARLSMED, INC.
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$29.6M
- Total assets
- $130.1M
- Market cap
- $300.9M
- Gross margin
- 75.3%
- Operating margin
- -60.5%
- Net margin
- -58.7%
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $50.5M
- Cost of revenue
- $12.5M
- Gross profit
- $38.0M
- Operating expenses
- $68.6M
- Operating income
- -$30.6M
- Income tax
- $0
- Net income
- -$29.6M
- EPS (basic)
- $-2.12
- EPS (diluted)
- $-2.12
Balance sheet
- Total assets
- $130.1M
- Current assets
- $126.7M
- Total liabilities
- $31.3M
- Current liabilities
- $14.3M
- Shareholders’ equity
- $98.9M
Cash flow
- Operating cash flow
- -$29.0M
- Investing cash flow
- -$25.5M
- Financing cash flow
- $100.1M
- Net cash flow
- $45.7M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $300.9M
- EPS (diluted)
- $-2.12
- Shares outstanding
- 27.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 23, 2025
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $29.6M.
- Gross margin of 75.3%, net margin -58.7%.
- Trading 35% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review CARLSMED, INC..
Write a review
News about CARLSMED, INC.
News & sentiment via Polygon.io
